GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,447.50GBp
11:19am EDT
Change (% chg)

17.50p (+1.22%)
Prev Close
1,430.00p
Open
1,424.50p
Day's High
1,451.00p
Day's Low
1,423.00p
Volume
4,776,014
Avg. Vol
9,120,494
52-wk High
1,658.39p
52-wk Low
1,296.50p

GSK.L

Chart for GSK.L

About

GlaxoSmithKline plc. (GSK) is a healthcare company. GSK develops pharmaceutical, vaccine and consumer healthcare products. The pharmaceuticals business develops and makes medicines to treat a range of acute and chronic diseases. The vaccines business produces paediatric and adult vaccines against a range of infectious diseases.... (more)

Overall

Beta: 0.47
Market Cap(Mil.): £69,586.77
Shares Outstanding(Mil.): 4,866.21
Dividend: 19.00
Yield (%): 5.59

Financials

  GSK.L Industry Sector
P/E (TTM): 6.78 37.06 38.97
EPS (TTM): 2.11 -- --
ROI: 31.01 16.25 15.59
ROE: 144.87 17.01 16.59
Search Stocks

BRIEF-GSK submits application for Japanese approval of asthma drug

* Submits Japan regulatory application for mepolizumab in severe eosinophilic asthma

22 May 2015

FTSE ends higher; 3i Group leads after strong earnings

LONDON, May 14 - Britain's FTSE 100 index ended higher on Thursday, with encouraging updates from companies such as 3i Group supporting the broader stock market.

14 May 2015

FTSE edges higher; 3i Group leads after strong earnings

LONDON, May 14 - Britain's blue-chip FTSE 100 index edged higher in afternoon trading on Thursday, with encouraging updates from companies such as 3i Group supporting the broader stock market.

14 May 2015

Britain's FTSE edges lower, miners weigh

LONDON, May 14 - Britain's blue-chip FTSE 100 index edged down on Thursday, broadly in line with European shares hit by a persistent bond-market sell-off, after a mixed bag of corporate earnings and weaker commodity prices.

14 May 2015

BRIEF-Bionor Pharma appoints Russell Greig Chairman

* Says Russell Greig, former President of Pharmaceuticals International, GlaxoSmithKline plc, joins the Board as Chairman

13 May 2015

Hunt for AIDS cure accelerates as GSK and U.S. experts link up

LONDON - Britain's GlaxoSmithKline, which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.

10 May 2015

Hunt for AIDS cure accelerates as GSK and U.S. experts link up

LONDON, May 11 - Britain's GlaxoSmithKline , which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.

10 May 2015

UPDATE 2-New GSK chairman backs CEO Witty to stay at helm

LONDON, May 7 - GlaxoSmithKline's new chairman Philip Hampton has thrown his support behind the company's current structure and chief executive despite pressure from some shareholders for a change.

07 May 2015

UPDATE 4-Gridlock looms in Britain; last election poll sees no clear winner

* GRAPHIC: http://graphics.thomsonreuters.com/15/UK-election/index.html (Adds leaders' tweets, French finance minister)

07 May 2015

New GSK chairman backs CEO Witty to stay at helm

LONDON, May 7 - GlaxoSmithKline's new chairman Philip Hampton expressed support for the company's current structure and its chief executive on Thursday while speaking to reporters after the drugmaker's annual meeting.

07 May 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks